Table 2.
Perioperative features between bisoprolol and placebo groups.
| Perioperative features | Bisoprolol (N = 57) | Placebo (N = 55) | P value |
|---|---|---|---|
| Thoracic surgery | 32 (56.1%) | 31 (56.4%) | 1.000 |
| Thoracotomy/lobectomy | 19 (33.3%) | 15 (27.3%) | |
| Video-assisted thoracoscopic surgery | 13 (22.8%) | 16 (29.1%) | |
| Vascular surgery | 25 (43.9%) | 24 (43.6%) | 1.000 |
| Artery bypass graft | 9 (15.8%) | 10 (18.2%) | |
| Abdominal aortic aneurysm repair | 9 (15.8%) | 6 (10.9%) | |
| Percutaneous transluminal angioplasty | 5 (8.8%) | 6 (10.9%) | |
| Anesthesia | |||
| General | 56 (98.2%) | 52 (94.5%) | 0.395 |
| Epidural or spinal | 1 (1.8%) | 3 (5.5%) | |
| Preoperative hs-TNT (ng/L) | 9.5 ± 10.6 | 9.5 ± 11.1 | 0.796 |
| Postoperative peak hs-TNT (ng/L) | 18.8 ± 19.6 | 15.7 ± 19.1 | 0.928 |
| Preoperative NT-proBNP (ng/L) | 122.6 ± 257.2 | 128.8 ± 270.6 | 0.571 |
| Postoperative NT-proBNP (ng/L) | 586.2 ± 703.0 | 370.0 ± 809.6 | 0.752 |
| Preoperative hs-CRP (mg/L) | 3.6 ± 25.0 | 4.2 ± 15.5 | 0.581 |
| Postoperative hs-CRP (mg/L) | 135.0 ± 100.1 | 111.0 ± 75.0 | 0.158 |
| Preoperative creatinine (mg/dL) | 1.2 ± 1.17 | 1.19 ± 1.16 | 0.616 |
| Postoperative creatinine (mg/dL) | 1.2 ± 1.4 | 1.0 ± 0.5 | 0.844 |
| RCRI 0 | 40 (70.2%) | 37 (67.3%) | 0.906 |
| RCRI 1 | 13 (22.8%) | 15 (27.3%) | |
| RCRI 2 | 2 (3.5%) | 2 (3.6%) | |
| RCRI 3 | 2 (3.5%) | 1 (1.8%) | |
hs-CRP high-sensitive C-reactive protein, hs-TnT high-sensitive troponin-T, NT-proBNP N-terminal-pro B-type natriuretic peptide, RCRI revised cardiac risk index.